id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2024-P-3293-0011,FDA,FDA-2024-P-3293,Final Response Letter from FDA CDER to Newcastle Bioscience LLC,Other,Approval,2024-12-27T05:00:00Z,2024,12,2024-12-27T05:00:00Z,,2024-12-27T20:32:43Z,,0,0,090000648688ca84
FDA-2024-P-3293-0009,FDA,FDA-2024-P-3293,Suitability Petition Amendment from Newcastle Bioscience LLC,Other,Amendment,2024-08-01T04:00:00Z,2024,8,2024-08-01T04:00:00Z,,2024-08-01T20:31:12Z,,0,0,09000064866136a4
FDA-2024-P-3293-0010,FDA,FDA-2024-P-3293,Attachment 1 - Petition Letter Updated,Supporting & Related Material,Background Material,2024-08-01T04:00:00Z,2024,8,,,2024-08-01T20:31:36Z,,0,0,09000064866136aa
FDA-2024-P-3293-0008,FDA,FDA-2024-P-3293,Completeness Assessment Correspondence,Other,Assessment Document or Analysis,2024-07-30T04:00:00Z,2024,7,2024-07-30T04:00:00Z,,2024-08-29T17:07:04Z,,0,0,090000648660e301
FDA-2024-P-3293-0005,FDA,FDA-2024-P-3293,Lacosamide 2024 A3,Supporting & Related Material,Background Material,2024-07-15T04:00:00Z,2024,7,,,2024-07-15T12:34:39Z,,0,0,09000064865ec7b9
FDA-2024-P-3293-0006,FDA,FDA-2024-P-3293,Lacosamide 2024 A4,Supporting & Related Material,Background Material,2024-07-15T04:00:00Z,2024,7,,,2024-07-15T12:34:52Z,,0,0,09000064865ec7bc
FDA-2024-P-3293-0003,FDA,FDA-2024-P-3293,Lacosamide 2024 A1,Supporting & Related Material,Background Material,2024-07-15T04:00:00Z,2024,7,,,2024-07-15T12:34:08Z,,0,0,09000064865ec7b7
FDA-2024-P-3293-0002,FDA,FDA-2024-P-3293,Acknowledgment Letter from FDA DMS to Newcastle Bioscience LLC,Other,Acknowledgement Letter/Receipt,2024-07-15T04:00:00Z,2024,7,2024-07-15T04:00:00Z,,2024-07-15T12:33:52Z,,0,0,09000064865ec799
FDA-2024-P-3293-0004,FDA,FDA-2024-P-3293,Lacosamide 2024 A2,Supporting & Related Material,Background Material,2024-07-15T04:00:00Z,2024,7,,,2024-07-15T12:34:21Z,,0,0,09000064865ec7b8
FDA-2024-P-3293-0007,FDA,FDA-2024-P-3293,Lacosamide 2024 A5,Supporting & Related Material,Background Material,2024-07-15T04:00:00Z,2024,7,,,2024-07-15T12:35:10Z,,0,0,09000064865ec8a8
FDA-2024-P-3293-0001,FDA,FDA-2024-P-3293,Suitability Petition from Newcastle Bioscience LLC,Other,Petition(s),2024-07-12T04:00:00Z,2024,7,2024-07-12T04:00:00Z,,2024-12-26T18:45:26Z,,0,0,09000064865ec379